BR112017010483A2 - composição de reidratação oral e métodos da mesma - Google Patents
composição de reidratação oral e métodos da mesmaInfo
- Publication number
- BR112017010483A2 BR112017010483A2 BR112017010483-0A BR112017010483A BR112017010483A2 BR 112017010483 A2 BR112017010483 A2 BR 112017010483A2 BR 112017010483 A BR112017010483 A BR 112017010483A BR 112017010483 A2 BR112017010483 A2 BR 112017010483A2
- Authority
- BR
- Brazil
- Prior art keywords
- range
- oral rehydration
- rehydration composition
- methods
- composition
- Prior art date
Links
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000004383 Steviol glycoside Substances 0.000 abstract 1
- 241000209140 Triticum Species 0.000 abstract 1
- 235000021307 Triticum Nutrition 0.000 abstract 1
- 239000005862 Whey Substances 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 235000013339 cereals Nutrition 0.000 abstract 1
- 229960002303 citric acid monohydrate Drugs 0.000 abstract 1
- 229960001031 glucose Drugs 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 abstract 1
- 239000004223 monosodium glutamate Substances 0.000 abstract 1
- 235000013923 monosodium glutamate Nutrition 0.000 abstract 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 abstract 1
- 235000019799 monosodium phosphate Nutrition 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract 1
- 229930182488 steviol glycoside Natural products 0.000 abstract 1
- 235000019411 steviol glycoside Nutrition 0.000 abstract 1
- 150000008144 steviol glycosides Chemical class 0.000 abstract 1
- 235000019202 steviosides Nutrition 0.000 abstract 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 abstract 1
- 229940038773 trisodium citrate Drugs 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0618—Glutamic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0622—Glycine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/16—Potassium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1614—Sodium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5086—Xanthan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/548—Vegetable protein
- A23V2250/5482—Cereal protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
resumo composição de reidratação oral e métodos da mesma trata-se de uma composição de reidratação oral que compreende o seguinte: ácido l-glutâmico em uma faixa de cerca de 0,01% a cerca de 0,40% em p/p e glutamato monossódico em uma faixa de cerca de 0,05% a cerca de 0,80% em p/p; cerca de 1,50% em p/p de mono-hidrato de glicose; cerca de 0,20% em p/p de cloreto de sódio; cerca de 0,15% em p/p de cloreto de potássio; cerca de 0,35% em p/p de glicina; cerca de 0,30% em p/p de citrato trissódico; cerca de 0,15% em p/p de dihidrogenofosfato de sódio; cerca de 0,10% em p/p de goma xantana; 85% de extrato de glicosídeo de esteviol em uma faixa de cerca de 0,01% a cerca de 0,03% em p/p; cerca de 0,20% em p/p de mono-hidrato de ácido cítrico; soro do leite hidrolisado em uma faixa de cerca de 0,15% a cerca de 1,00% em p/p; cerca de 1,00% em p/p de trigo hidrolisado; compreende cereais como uma fonte de proteína; compreende cofatores de enzima; compreende um monossacarídeo. a composição de reidratação oral pode ser usada em seres humanos ou animais que sofrem de diarreia.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462081588P | 2014-11-19 | 2014-11-19 | |
US62/081,588 | 2014-11-19 | ||
PCT/IB2015/058699 WO2016079640A1 (en) | 2014-11-19 | 2015-11-11 | Oral rehydration composition and methods thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112017010483A2 true BR112017010483A2 (pt) | 2018-06-19 |
BR112017010483B1 BR112017010483B1 (pt) | 2022-04-05 |
Family
ID=54705233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017010483-0A BR112017010483B1 (pt) | 2014-11-19 | 2015-11-11 | Composição de reidratação oral e uso da mesma |
Country Status (25)
Country | Link |
---|---|
US (2) | US10463067B2 (pt) |
EP (2) | EP3685682B1 (pt) |
JP (1) | JP6822734B2 (pt) |
KR (1) | KR102493948B1 (pt) |
CN (1) | CN107205464B (pt) |
AU (1) | AU2015347971B2 (pt) |
BR (1) | BR112017010483B1 (pt) |
CA (1) | CA2968324C (pt) |
CL (1) | CL2017001255A1 (pt) |
CO (1) | CO2017005016A2 (pt) |
DK (1) | DK3220750T3 (pt) |
EA (1) | EA033940B1 (pt) |
ES (2) | ES2948402T3 (pt) |
HR (2) | HRP20230910T1 (pt) |
HU (2) | HUE063036T2 (pt) |
MX (2) | MX2017006475A (pt) |
MY (1) | MY178335A (pt) |
PE (1) | PE20171178A1 (pt) |
PH (1) | PH12017500931B1 (pt) |
PL (2) | PL3220750T3 (pt) |
PT (1) | PT3220750T (pt) |
RS (2) | RS60439B1 (pt) |
SI (1) | SI3685682T1 (pt) |
WO (1) | WO2016079640A1 (pt) |
ZA (1) | ZA201703443B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6822734B2 (ja) | 2014-11-19 | 2021-01-27 | カルマーナ・リミテッド | 経口補水組成物とその方法 |
CN111867400A (zh) * | 2018-03-15 | 2020-10-30 | 潘可士玛股份公司 | 用于改善哺乳动物健康和行为表现的饲料 |
DE202018105142U1 (de) * | 2018-04-29 | 2018-10-08 | Kalmarna Limited - CCS Trustees Limited | Zusammensetzungen zur oralen Verabreichung zum Beeinflussen der Nachkommenschaft von Säugetieren |
DE202018105143U1 (de) * | 2018-04-29 | 2018-10-05 | Kalmarna Limited - CCS Trustees Limited | Zusammensetzungen zum Nähren von Säugetieren |
WO2020039443A1 (en) * | 2018-08-23 | 2020-02-27 | Kalmarna Limited | Compositions and methods for controlling mammalian pathogens |
US20200396961A1 (en) * | 2019-06-18 | 2020-12-24 | Susu Pets, Llc | Container for an aqueous composition |
EP4003052A1 (en) * | 2019-07-29 | 2022-06-01 | Nutreco IP Assets B.V. | Electrolyte composition and methods of use |
CN111035651A (zh) * | 2019-12-19 | 2020-04-21 | 孙庆 | 一种改善口感和缓和胃刺激的补钾制剂及其制备 |
JP7463115B2 (ja) * | 2020-01-30 | 2024-04-08 | 森永乳業株式会社 | 電解質補給飲料及びその製造方法 |
PL242445B1 (pl) * | 2020-03-15 | 2023-02-20 | Anwipharma Spolka Z Ograniczona Odpowiedzialnoscia | Sposób otrzymywania preparatu i preparat zawierający elektrolity dla zwierząt kopytnych, zwłaszcza koni |
MX2023014015A (es) * | 2021-05-28 | 2024-02-08 | Coca Cola Co | Formulación aminoácidica hidratante y método de uso. |
IT202200014092A1 (it) * | 2022-07-04 | 2024-01-04 | Farm Del Corso Snc Di Ferri Sonia & C | Nuova composizione |
WO2024033533A1 (en) * | 2022-08-11 | 2024-02-15 | Unilever Ip Holdings B.V. | Hydration composition |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2539006A1 (fr) * | 1983-01-12 | 1984-07-13 | Agronomique Inst Nat Rech | Composition rehydratante utilisable notamment dans l'alimentation de jeunes animaux ne pouvant plus digerer normalement le lait et complement pour sa preparation |
GB8512345D0 (en) * | 1985-05-15 | 1985-06-19 | Scras | Anti-diarrhea compositions |
DE3684564D1 (de) * | 1985-11-18 | 1992-04-30 | Beecham Group Plc | Veterinaere zusammensetzungen. |
GB9212737D0 (en) | 1992-06-16 | 1992-07-29 | Norbrook Lab | Veterinary product |
US5489440A (en) | 1995-03-06 | 1996-02-06 | Abbott Laboratories | Rice flour-based oral rehydration solution |
GB9609993D0 (en) | 1996-05-14 | 1996-07-17 | Norbrook Lab Ltd | Oral rehydration product |
US7026298B2 (en) * | 2001-06-04 | 2006-04-11 | Abbott Laboratories | Oral rehydration compositions |
US7160565B2 (en) * | 2003-03-31 | 2007-01-09 | Breakthru Products, Llc | Hydration beverage and method of delivering nutrients |
JP4528925B2 (ja) * | 2003-05-30 | 2010-08-25 | 独立行政法人理化学研究所 | アミノ酸組成物及び補液 |
US8956652B2 (en) * | 2005-09-15 | 2015-02-17 | Tower Laboratories, Ltd. | Effervescent rehydrating beverage tablet/granules |
JP2014523430A (ja) * | 2011-07-01 | 2014-09-11 | ドリップ ドロップ,インク. | 経口補水組成物 |
US8557301B2 (en) * | 2011-07-01 | 2013-10-15 | Drip Drop, Inc. | Oral rehydration composition |
JP6346558B2 (ja) * | 2012-03-09 | 2018-06-20 | 株式会社明治 | 水分吸収性に優れた飲食品 |
CN102824362B (zh) * | 2012-09-20 | 2014-03-12 | 西安安健药业有限公司 | 一种口服补液盐的药物组合物 |
CN103479664B (zh) * | 2013-09-24 | 2015-01-07 | 辽宁亿灵科创生物医药科技有限公司 | 一种液态口服补液盐 |
JP6822734B2 (ja) | 2014-11-19 | 2021-01-27 | カルマーナ・リミテッド | 経口補水組成物とその方法 |
-
2015
- 2015-11-11 JP JP2017546059A patent/JP6822734B2/ja active Active
- 2015-11-11 PL PL15801252T patent/PL3220750T3/pl unknown
- 2015-11-11 HU HUE20155784A patent/HUE063036T2/hu unknown
- 2015-11-11 DK DK15801252.6T patent/DK3220750T3/da active
- 2015-11-11 CN CN201580073826.3A patent/CN107205464B/zh active Active
- 2015-11-11 PE PE2017000885A patent/PE20171178A1/es unknown
- 2015-11-11 EP EP20155784.0A patent/EP3685682B1/en active Active
- 2015-11-11 HR HRP20230910TT patent/HRP20230910T1/hr unknown
- 2015-11-11 PT PT158012526T patent/PT3220750T/pt unknown
- 2015-11-11 HU HUE15801252A patent/HUE050306T2/hu unknown
- 2015-11-11 CA CA2968324A patent/CA2968324C/en active Active
- 2015-11-11 BR BR112017010483-0A patent/BR112017010483B1/pt active IP Right Grant
- 2015-11-11 EP EP15801252.6A patent/EP3220750B1/en active Active
- 2015-11-11 KR KR1020177016671A patent/KR102493948B1/ko active IP Right Grant
- 2015-11-11 US US15/527,724 patent/US10463067B2/en active Active
- 2015-11-11 PL PL20155784.0T patent/PL3685682T3/pl unknown
- 2015-11-11 EA EA201791111A patent/EA033940B1/ru unknown
- 2015-11-11 RS RS20200717A patent/RS60439B1/sr unknown
- 2015-11-11 ES ES20155784T patent/ES2948402T3/es active Active
- 2015-11-11 RS RS20230672A patent/RS64505B1/sr unknown
- 2015-11-11 ES ES15801252T patent/ES2799903T3/es active Active
- 2015-11-11 MX MX2017006475A patent/MX2017006475A/es unknown
- 2015-11-11 MY MYPI2017701808A patent/MY178335A/en unknown
- 2015-11-11 WO PCT/IB2015/058699 patent/WO2016079640A1/en active Application Filing
- 2015-11-11 SI SI201531961T patent/SI3685682T1/sl unknown
- 2015-11-11 AU AU2015347971A patent/AU2015347971B2/en active Active
-
2017
- 2017-05-16 CL CL2017001255A patent/CL2017001255A1/es unknown
- 2017-05-17 MX MX2021014983A patent/MX2021014983A/es unknown
- 2017-05-18 ZA ZA2017/03443A patent/ZA201703443B/en unknown
- 2017-05-19 CO CONC2017/0005016A patent/CO2017005016A2/es unknown
- 2017-05-19 PH PH12017500931A patent/PH12017500931B1/en unknown
-
2018
- 2018-10-29 US US16/173,292 patent/US20190059434A1/en not_active Abandoned
-
2020
- 2020-06-10 HR HRP20200940TT patent/HRP20200940T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017010483A2 (pt) | composição de reidratação oral e métodos da mesma | |
JP2017535616A5 (pt) | ||
BR112018013975A2 (pt) | métodos para melhoria da produção de leite por administração de consórcios microbianos | |
EA201391823A1 (ru) | Высушенные распылением штаммы/клетки лактобактерий и их применение против helicobacter pylori | |
BR112015032918A8 (pt) | células encapsuladas liofilizadas, métodos para sua liofilização e para sua preparação, seus usos, e composições | |
IN2015MU00865A (pt) | ||
NZ602685A (en) | Concentrated protein formulations and uses thereof | |
BR112013028907A2 (pt) | conjugados de proteína-agente ativo e método para preparar os mesmos | |
MX2018014631A (es) | Formulacion de neurotoxina. | |
MX2018014083A (es) | Composiciones nutritivas para la proteccion cardiaca en animales de compañia. | |
BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo | |
Hasimun et al. | Potential alpha-glucosidase inhibitor from selected Zingiberaceae family | |
PE20160012A1 (es) | Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral | |
BR112018011352A2 (pt) | hidratação para animais | |
CO2019012484A2 (es) | Disminución de homocisteína mediada por enzimas humanas para el tratamiento de pacientes con hiperhomocisteinemia y homocistinuria | |
CL2013003057A1 (es) | Composicion farmaceutica de aerosol en forma de solución acuosa para nebulización que comprende iloprost, que proporciona una dosis unica eficaz aerolizada para inhalacion de bolo en un periodo de menos de 2 minutos; kit farmacéutio, util en el tratamiento de hipertension arterial pulmonar. | |
BR112013027474A2 (pt) | composições que melhoram a palatabilidade | |
MX2020011923A (es) | Metodos y composiciones para incrementar los cuerpos cetonicos en animales. | |
MX2020007971A (es) | Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar. | |
BR112022012629A2 (pt) | Controle de histamina para promover saúde e controlar enterocolite usando composições probióticas e/ou enzimas de degradação de histamina | |
AR114427A1 (es) | Una composición de alimento para rumiantes que comprende polipéptidos que tienen actividad de muramidasa y métodos para mejorar la digestibilidad en rumiantes | |
MX349837B (es) | Composicion de transglutaminasa seca. | |
BR112024001179A2 (pt) | Aminoácido supramolecular ou sal do mesmo, e método de preparação do mesmo e aplicação do mesmo | |
BR112018069201A2 (pt) | composição enzimática e método para a preparação de uma composição enzimática em forma líquida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: A23L 1/00 Ipc: A23L 33/175 (2016.01) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/11/2015, OBSERVADAS AS CONDICOES LEGAIS. |